Korro Bio (KRRO) risk factors

Item 1A of every Korro Bio, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open KRRO in Gloom →

Korro Bio's chart, financials and news, free in your browser.Open KRRO in Gloom →

FY2025 10-K risk factors
94 risks8 new13 dropped33 reworded
Korro Bio faces severe concentration risk on lead candidate KRRO-121 targeting hyperammonemia, with a planned IND filing in the second half of 2026.
Filed Mar 12, 2026
FY2024 10-K risk factors
99 risks
Korro Bio faces substantial operating losses and an accumulated deficit of $266.6 million as of December 31, 2024.
Filed Mar 18, 2025